[HTML][HTML] Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an …

…, NJ DeVito, R Croker, H Drysdale, J Cockburn, J Parry… - The Lancet, 2021 - thelancet.com
Background COVID-19 has disproportionately affected minority ethnic populations in the UK.
Our aim was to quantify ethnic differences in SARS-CoV-2 infection and COVID-19 …

Compliance with legal requirement to report clinical trial results on ClinicalTrials. gov: a cohort study

NJ DeVito, S Bacon, B Goldacre - The Lancet, 2020 - thelancet.com
Background Failure to report the results of a clinical trial can distort the evidence base for
clinical practice, breaches researchers' ethical obligations to participants, and represents an …

[HTML][HTML] Case fatality risk of the SARS-CoV-2 variant of concern B. 1.1. 7 in England, 16 November to 5 February

…, J Parry, F Hester, S Harper, NJ DeVito… - …, 2021 - eurosurveillance.org
The SARS-CoV-2 B.1.1.7 variant of concern (VOC) is increasing in prevalence across Europe.
Accurate estimation of disease severity associated with this VOC is critical for pandemic …

Severity of severe acute respiratory system coronavirus 2 (SARS-CoV-2) alpha variant (B. 1.1. 7) in England

…, J Parry, F Hester, S Harper, NJ DeVito… - Clinical Infectious …, 2022 - academic.oup.com
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) alpha
variant (B.1.1.7) is associated with higher transmissibility than wild-type virus, becoming the …

Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource

B Goldacre, NJ DeVito, C Heneghan, F Irving, S Bacon… - bmj, 2018 - bmj.com
Objectives To ascertain compliance rates with the European Commission’s requirement that
all trials on the EU Clinical Trials Register (EUCTR) post results to the registry within 12 …

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the …

…, EPK Parker, WJ Hulme, SCJ Bacon, NJ DeVito… - bmj, 2022 - bmj.com
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody)
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …

Catalogue of bias: publication bias

NJ DeVito, B Goldacre - BMJ Evidence-Based Medicine, 2019 - ebm.bmj.com
Background Dickersin and Min define publication bias as the failure to publish the results of
a study ‘on the basis of the direction or strength of the study findings’. 1 This non-publication …

Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England

…, CT Rentsch, R Mathur, A Schultze, NJ DeVito… - bmj, 2021 - bmj.com
Objective To investigate whether risk of infection with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and outcomes of coronavirus disease 2019 (covid-19) differed …

[HTML][HTML] Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic …

CT Rentsch, NJ DeVito, B MacKenna… - The Lancet …, 2021 - thelancet.com
Background Hydroxychloroquine has been shown to inhibit entry of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) into epithelial cells in vitro, but clinical studies …

Reducing bias and improving transparency in medical research: a critical overview of the problems, progress and suggested next steps

SH Bradley, NJ DeVito, KE Lloyd… - Journal of the Royal …, 2020 - journals.sagepub.com
In recent years there has been increasing awareness of problems that have undermined
trust in medical research. This review outlines some of the most important issues including …